Macrocure (NASDAQ: MCUR) shares advanced Friday ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Momentum Movers Trader Talk

KaloBios Pharma (KBIO) Receives NASDAQ Delisting NoticeNovember 23, 2015 5:46 PM Newly-Named KaloBios Pharma (KBIO) CEO Shkreli Briefly Comments on Twitter About AppointmentNovember 20, 2015 6:38 AM KaloBios Pharma (KBIO) Names Martin Shkreli as CEONovember 20, 2015 6:16 AM KaloBios Pharmaceuticals, Inc. Appoints Martin Shkreli CEO and Announces New FinancingNovember 19, 2015 11:33 PM Needham & Company Drops Coverage of KaloBios Pharma (KBIO) November 19, 2015 4:42 PM Shock of Epic Short Squeeze in KaloBios Pharma (KBIO) Reverberates Across Wall StreetNovember 19, 2015 1:36 PM Filing Shows Shkreli Bought Added 440K KaloBios Pharma (KBIO) Shares on 11/18 at $2.02November 19, 2015 1:03 PM Form 4 KALOBIOS PHARMACEUTICALS For: Nov 18 Filed by: Shkreli MartinNovember 19, 2015 12:59 PM Marek Biestek Bought 200K Shares of KaloBios Pharma (KBIO) November 19, 2015 12:47 PM KaloBios Pharma (KBIO) In Discussions with Shkreli Group About Continuing OperationsNovember 19, 2015 6:22 AM KaloBios Confirms Communications with Majority Shareholder GroupNovember 18, 2015 7:27 PM Anthion Partners II Buys ~700K Shares of KaloBios Pharma (KBIO), Adding to MadnessNovember 18, 2015 5:39 PM Celladon (CLDN) Moves Higher in Concert with KaloBios Pharma (KBIO) Following Shkreli StakeNovember 18, 2015 5:24 PM With Shkreli Spike, KaloBios Pharma (KBIO) May Be Overvalued by a Factor of 4November 18, 2015 4:57 PM KaloBios Pharma (KBIO) Pops on Shkreli Insider BuyNovember 18, 2015 4:25 PM